- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Beam Therapeutics appoints Eric Foster as Chief Commercial Officer | ||
| Mo | First-ever World Chronic Hand Eczema Day launches on 5 October | ||
| Mo | Nuclera appoints Carl Raimond as CEO | ||
| Fr | Galderma's Nemluvio shows sustained improvements in moderate-to-severe atopic dermatitis | ||
| Fr | Inizio Evoke appoints Barbara Patchefsky as Global Client Lead | ||
| Do | Inizio Evoke appoints Brian Gundich as EVP, AI Enablement | ||
| Do | MSD announces phase 2 results for tulisokibart in moderate to severe hidradenitis suppurativa | ||
| 30.09. | Roche's fenebrutinib receives FDA filing acceptance for relapsing and primary progressive MS | ||
| 30.09. | Inizio Evoke appoints Jake Vander Linden as President, Media | ||
| 29.09. | Ogsiveo recommended by NICE to treat rare soft tissue tumours | ||
| 29.09. | Heart, humanity and the work behind the words | ||
| 28.09. | Empowering expertise in an age of complexity | ||
| 28.09. | Lilly gets FDA approval for severe alopecia areata treatment for paediatric patients | ||
| 25.09. | Strengthening engagement with HCPs needs deep understanding not digital bombardment | ||
| 25.09. | MHRA approves Pharma Mar's lurbinectedin for extensive-stage small cell lung cancer | ||
| 24.09. | Pharmaceutical Market Europe - September 2026 | ||
| 24.09. | From activity to accountability: the omnichannel metrics that pharma leadership actually acts on | ||
| 24.09. | Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal | ||
| 23.09. | AstraZeneca's Trixeo gets EU approval for asthma maintenance treatment | ||
| 23.09. | Engitix appoints Sonia Quaratino as EVP Chief Medical Officer | ||
| 22.09. | CSL Seqirus announces strengthened vaccine partnership with UK government | ||
| 22.09. | Galimedix establishes Alzheimer's Disease Scientific Advisory Board | ||
| 21.09. | The Emmes Group's Board of Directors has appointed Rama Kondru as CEO | ||
| 21.09. | Novartis' Cosentyx gets positive CHMP opinion for polymyalgia rheumatica | ||
| 18.09. | PMi Awards 2026 - the winners and highlights |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.